CBD-CONTAINING BEVERAGE

Abstract

The invention relates to a CBD-containing liquid formulation, and in particular to a beverage comprising at least one emulsifier.

Claims

1.-11. (canceled)

12. A liquid formulation comprising cannabidiol (CBD) and water and at least one emulsifier for use in the application of a dosage of 1 mg/kg to 5 mg/kg (body weight) CBD in a human, wherein the cannabidiol is synthetic cannabidiol or purified cannabidiol from a cannabis extract.

13. The liquid formulation according to claim 12, comprising CBD in the range of 50 mg/L to 300 mg/L.

14. The liquid formulation according to claim 12, comprising CBD in the range of 50 mg/L to 100 mg/L.

15. The liquid formulation according to claim 12, wherein the emulsifier is a non-ionic, anionic, cationic or amphoteric emulsifier.

16. The liquid formulation according to claim 14, wherein the emulsifier is a non-ionic, anionic, cationic or amphoteric emulsifier.

17. The liquid formulation according to claim 12, wherein the emulsifier is selected from the group consisting of polysorbates, polyoxyethylene sorbitan fatty acid ester, rubbers, gum arabic, pectins, starches and modified starches, proteins and mixtures thereof.

18. The liquid formulation according to claim 16, wherein the emulsifier is selected from the group consisting of polysorbates, Tween 20, Tween 60, Tween 80, rubbers, gum arabic, pectins, starches, Purity Gum, caseinates from milk and mixtures thereof.

19. A beverage or base material comprising a liquid formulation comprising cannabidiol and water and at least one emulsifier, wherein the cannabidiol is synthetic cannabidiol or purified cannabidiol from a cannabis extract,

20. The beverage or base material according to claim 19, wherein the beverage or base material is selected from the group consisting of energy drink, mineral water, lemonade, tonic water, sports, mineral, fruit, fruit juice, milk, whey, soft drink, alcoholic beverage and as a drinking water preparation.

21. The beverage or base material according to claim 19, wherein the beverage or base material is selected from the group consisting of energy drink, mineral water, lemonade, tonic water, sports, mineral, fruit, fruit juice, milk, whey, soft drink, beer and as a drinking water preparation.

22. The beverage or base material according to claim 19, comprising 50 mg/L to 300 mg/L CBD.

23. The beverage or base material according to claim 22, comprising 50 mg/L to 100 mg/L CBD.

24. The beverage or base material according to claim 16, wherein the emulsifier is selected from the group consisting of polysorbates, polyoxyethylene sorbitan fatty acid ester, rubbers, gum arabic, pectins, starches and modified starches, proteins, caseinates, beeswax, lecithin, sterols and mixtures thereof.

25. The beverage or base material according to claim 16, wherein the emulsifier is selected from the group consisting of polysorbates, Tween 20, Tween 60, Tween 80, rubbers, gum arabic, pectins, starches and modified starches, proteins, caseinates, beeswax, lecithin, sterols and mixtures thereof.

26. A food or functional food comprising the beverage or base material according to claim 19.

27. A product comprising a liquid formulation comprising cannabidiol (CBD) and water and at least one emulsifier, comprising 50 mg/L to 300 mg/L CBD, for use for increased concentration, increased physical, athletic and cognitive performance and/or increased memory function, wherein the cannabidiol is synthetic cannabidiol or purified cannabidiol from a cannabis extract.

28. The product as claimed in claim 27, wherein the product is a pharmaceutical product or a dietary supplement comprising a liquid formulation comprising cannabidiol and water and at least one emulsifier, comprising 50 mg/L to 100 mg/L CBD, for use for increased concentration, increased physical, athletic and cognitive performance and/or increased memory function, wherein the cannabidiol is synthetic cannabidiol or purified cannabidiol from a cannabis extract.

Description

[0039] FIG. 1 electropharmacogram (1.0 mg/kg CBD), relative change pattern over time:

[0040] Time-dependent progression of the electric output (spectral power) (ordinate) in percent from the 45-minute long pre-drug base line (values) in four brain regions of freely moving rats in the presence of a vehicle (4 ml/kg). The frequency ranges are depicted as bars on the abscissa, specifically delta (1), theta (2), alpha1 (3), alpha2 (4), beta1a (5), beta1b (6) and gamma spectral power (7) from left to right, depending on the named brain region. The statistical significance is represented in stars compared to the control group (vehicle): *=p<0.05; **=p<0.01.

[0041] FIG. 2, electropharmacogram (5.0 mg/kg CBD), otherwise as in FIG. 1.

[0042] FIG. 3, electropharmacogram (15.0 mg/kg CBD), otherwise as in FIG. 1.